Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05697341
Other study ID # YRS0001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2021
Est. completion date June 1, 2022

Study information

Verified date January 2023
Source Ain Shams University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nephrolithiasis is the third most common disease of the urinary tract. As minimally invasive technologies develop, shock wave lithotripsy (SWL), retrograde intrarenal surgery (RIRS), and percutaneous nephrolithotomy (PCNL) are different surgeries to treat renal stones. Aim of the Study is to compare results, safety and outcome of Ultra mini PCNL versus stented extracorporeal shock wave lithotripsy (SWL) for the management of renal calculi from 10 - 20 mm. Patients were randomized to either Ultra-Mini-Percutaneous nephrolithotomy group or stented SWL group via the closed envelope method. Patient data was collected preoperatively, immediately postoperatively and 2 and 4 weeks postoperatively to assess operative time, hospital stay, complications regarding fever, hematuria and need for blood transfusion, residual stones and need for retreatment.


Description:

Nephrolithiasis is the third most common disease of the urinary tract, following urinary tract infections and Prostatic diseases. It also has a 1-year recurrence rate of 7% and 10-year recurrence rate of 50%. Management of renal stones had seen a great shift over the last ten years. The need to find a balance between morbidity and stone clearance is always the milestone of treatment choice. Low risk procedure with high retreatment percentage vs another relatively higher risk procedure with lower retreatment chances. As minimally invasive technologies develop, shock wave lithotripsy (SWL), retrograde intrarenal surgery (RIRS), and percutaneous nephrolithotomy (PCNL) are different surgeries to treat renal stones. Open, laparoscopic, and robotic surgeries have their place only in highly selected patients. In the European Association of Urology (EAU) Guidelines on Urolithiasis, PCNL is a treatment of choice (TOC) for renal stones > 20 mm, SWL or RIRS is the first-line therapy for renal stones < 10 mm, and SWL or endourologic treatment (all PCNL and ureteroscopic interventions) can be performed for stones 10-20 mm. SWL is a minimally invasive intervention with good patient tolerance; it is regarded as the first line treatment for nephrolithiasis < 20 mm in size. Poor clearance of lower calyceal stone fragments due to gravity or unfavorable infundibulopelvic angle limits the efficacy of SWL for treating lower calyceal stones. flexible ureteroscopy increased quality and performance of upper urinary tract exploration, allowing the treatment the majority of stones at all sites. Experiences with RIRS have revealed higher stone-free rate (SFR) with less risk of renal damage and bleeding. Nevertheless, RIRS is also associated with some disadvantages as the possible need for staged procedures, risk of ureteral injuries and the costs of acquisition and maintenance of the complex endourological instruments and those issues can be possible factors that might have limited the capillary diffusion of this endoscopic procedure. Percutaneous nephrolithotripsy (24-30F) remains the standard procedure for treating large renal calculi. While achieving high SFR, it also has many drawbacks such as bleeding, postoperative pain, and a long recovery period due to its large access tract, so the mini percutaneous nephrolithotripsy (14-22F) with a smaller tract size came into existence. To reduce renal parenchymal injury associated with standard PCNL, minimally invasive PCNL with a smaller tract size has been developed. Depending on the size of the access tract, minimally invasive PCNL can be classified into Mini-PCNL (14- 22Fr), Ultra-mini-PCNL (11-13Fr). PCNL carried a significantly higher stone free rate than RIRS, especially for lower calyceal stones (OR=2.65, P=.003), however Mini-PCNL was at the expense of a longer hospital stay and an increased hemoglobin drop. Although PCNL could exhibit a stone free rate of 93.8%, a global survey revealed that it carried a complication rate of up to 14.5%. Ulra-mini-PCNL offer a particular advantage for difficult to access calculi, impacted lower pole calculi with an acute infundibular angle or stones in a calyceal diverticulum, with the greater advantage of reduced bleeding. This study was conducted at Urology department, Faculty of Medicine, Ain Shams University. Inclusion criteria included patients between 18 and 60 years, complaining of radioopaque renal stones ranging from 10-20 mm with BMI not exceeding 40 Exclusion criteria were patients who had radiolucent stones, smaller than 10 mm or larger than 20 mm, with congenital renal anomalies or spinal deformity or BMI exceeding 40. Patients with uncorrected bleeding diathesis or pregnant females or untreated urinary tract infection were also excluded. In this study patients were recruited from the outpatient urology clinic between March 2021 till March 2022. Using Power Analysis and Sample Size Software version 15 program for sample size calculation after reviewing results from a previous study (Zhang et al, 2019) we assume a medium effect size difference between the two groups regarding the stone-free rate ( d=0.6), based on these findings sample size of 90 patients (45 per group) achieve 80% power to reject the null hypothesis of zero effect size when the population effect size is 0.60 and the significance level (alpha) is 0.050 using a two-sided z test. Patients were randomized to either Group A Ultra-Mini-Percutaneous nephrolithotomy group or Group B stented SWL group via the closed envelope method. Preoperative evaluation including careful history taking, general and local examination, urine analysis, perioperative labs (CBC, bleeding profile, liver and renal functions), Computerized tomography Urinary Tract (CTUT) with Hounsfield unit estimation and Plain X-ray of the urinary tract (KUB). All patients were given perioperative antibiotic prophylaxis. In The Ultra-Mini-percutaneous nephrolithotomy group, a 5 Fr open-ended ureteral catheter was introduced in the renal pelvis, and a retrograde pyelogram was performed in the Lithotomy position after the induction of general anesthesia. Patients were then repositioned to the prone position. Ultra-mini-PCNLs were done in a prone position by a single consultant. The desired calyx was punctured with a Cook diamond tip puncture needle under fluoroscopy guidance using standard bull's eye technique. Single tract dilatation with One Step Dilator (11Fr), with central channel for guide wires with its Operating Sheath (Storz Dilator and Operating Sheaths for Minimal Invasive PCNL (MIP) XS) under fluoroscopy guidance. Storz Nephroscope for MIP XS / S along with Swiss Lithoclast master pneumatic lithotripter with 1/0.8 mm probe was used for stone fragmentation. Stone fragments are flushed out on rapid removal of the endoscope, due to a 'vortex' effect and with wash through the operating sheath using a 6 Fr. nelaton catheter. In the stented Extracorporeal ShockWave Lithotripsy (ESWL) group, a 5 Fr open-ended ureteral catheter was introduced in the renal pelvis, and a retrograde pyelogram was performed in the Lithotomy position after the induction of general anaesthesia JJ is applied either 5-26 or 5-28 according to the patient. ESWL was administered with an electromagnetic shockwave lithotripter (Siemens electromagnetic lithotripters devices). Patients were positioned supine with the shock head from the back. Fluoroscopy was used for the localization and monitoring of stone fragmentation. All patients received shocks at a frequency of 60/min. An average of approximately 2500-3000 shocks was targeted in all patients. Follow up of patients was done postoperative immediately including careful and detailed history taking and examination including pain, fever, sepsis, and hematuria. Serum Hb level, S.creatinine, BUN, Na+, K+


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date June 1, 2022
Est. primary completion date March 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - patients between 18 and 60 years - complaining of radioopaque renal stones ranging from 10-20 mm. - BMI not exceeding 40 Exclusion Criteria: - radiolucent stones, - smaller than 10 mm or larger than 20 mm stones - congenital renal anomalies or spinal deformity - BMI exceeding 40. - Patients with uncorrected bleeding diathesis - pregnant females - untreated UTI.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Ultra-Mini-PCNL
treatment to extract or disintegrate renal stones
Stented SWL
treatment to disintegrate renal stones in the presence of a JJ

Locations

Country Name City State
Egypt Ain Shams University, Faculty of medicine Cairo Abbassia

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

References & Publications (4)

Bozzini G, Verze P, Arcaniolo D, Dal Piaz O, Buffi NM, Guazzoni G, Provenzano M, Osmolorskij B, Sanguedolce F, Montanari E, Macchione N, Pummer K, Mirone V, De Sio M, Taverna G. A prospective randomized comparison among SWL, PCNL and RIRS for lower calyceal stones less than 2 cm: a multicenter experience : A better understanding on the treatment options for lower pole stones. World J Urol. 2017 Dec;35(12):1967-1975. doi: 10.1007/s00345-017-2084-7. Epub 2017 Sep 5. — View Citation

Gao XS, Liao BH, Chen YT, Feng SJ, Gao R, Luo DY, Liu JM, Wang KJ. Different Tract Sizes of Miniaturized Percutaneous Nephrolithotomy Versus Retrograde Intrarenal Surgery: A Systematic Review and Meta-Analysis. J Endourol. 2017 Nov;31(11):1101-1110. doi: 10.1089/end.2017.0547. Epub 2017 Oct 30. — View Citation

Kim CH, Chung DY, Rha KH, Lee JY, Lee SH. Effectiveness of Percutaneous Nephrolithotomy, Retrograde Intrarenal Surgery, and Extracorporeal Shock Wave Lithotripsy for Treatment of Renal Stones: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2020 Dec 30;57(1):26. doi: 10.3390/medicina57010026. — View Citation

Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petrik A, Turk C. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015 Apr;67(4):750-63. doi: 10.1016/j.eururo.2014.10.029. Epub 2014 Nov 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Stone-free status The complete stone clearance or presence of clinically insignificant residual fragments (<4 mm) 2 or 4 weeks after the final procedure was regarded as stone-free at 2 or 4 weeks after ultra-mini-PCNL or stented SWL
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06070714 - Efficiency and Safety of Holmium Laser With Moses Technology Versus SuperPulsed Laser System With Thulium Fiber Laser on Renal Stones N/A
Completed NCT04077359 - Prospective Trial for Examining Hematuria Using Computed Tomography N/A
Enrolling by invitation NCT04071340 - The Natural History of Minimally Symptomatic Nonobstructing Calyceal Stones
Completed NCT05589649 - Erector Spinae Versus Paravertebral in Pediatric PCNL N/A
Recruiting NCT05833386 - Effect of Preoperative Silodosin on Feasibility of Ureteral Access Sheath Insertion N/A
Recruiting NCT05634434 - Uric Acid Based Renal Stones: Clinical, Metabolic and Genetic Characterization
Completed NCT03046888 - ROBOTIC PYELOLITHIOTOMY VERSUS PERCUTANEOUS NEPHROLITHOTOMY (PCNL). N/A
Active, not recruiting NCT06110247 - Evaluation of Renal Oxygenation by NIRS in Pediatric Endourologic Stone Surgery
Not yet recruiting NCT06131151 - Comparison Between External Oblique Intercostal Block and Erector Spinae Plane Block in PCNL N/A
Not yet recruiting NCT03939325 - ESWL on Disintegration of Renal Stones
Not yet recruiting NCT04871984 - Effectiveness of Holmium and Thulium Lasers With Ureteroscopy for Urinary Lithiasis
Withdrawn NCT03608098 - Long Pulse Versus Short Pulse Laser Dusting for Renal Stones N/A
Completed NCT02067221 - Comparison of Surgical Outcomes Between MPCNL and RIRS N/A
Active, not recruiting NCT03189264 - Percutaneous Nephrolithotomy for Treatment of Kidney Stones Greater Than 2 cm N/A
Recruiting NCT06101563 - Duration Between Drainage and Ureteroscopic Lithotripsy N/A
Recruiting NCT05384197 - Enhanced Versus Extended Preoperative Antibiotic Prophylaxis Regimens for Retrograde Intrarenal Surgery in High Infectious Risk Patients Phase 3
Enrolling by invitation NCT05121168 - Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy Phase 4
Not yet recruiting NCT06185387 - Changes Post Percutaneous Nephrolithotomy
Completed NCT03349099 - Impact Ureteral Sheath Design During Ureteroscopy N/A
Completed NCT03318926 - Increased Tea Consumption is Associated With a Decreased Risk of Renal Stone Disease in a Taiwanese Population N/A